Fluorinase - an enzymatic process for the generation of organo-fluorine compounds

submit enquiry
Life Sciences
Life Sciences

University: University of St Andrews

Sector(s): Life Sciences, Healthcare & Pharmaceuticals

About Opportunity:

Such compounds are also prevalent in the material industry, such as ferromagnetic materials and TeflonTM Our technology allows a novel approach to the generation of stable fluorine-containing compounds which offers significant and advantageous changes to physical and pharmacokinetic properties.  Additionally, it is capable of producing radiolabelled fluorinase compounds for positron emission tomography scans (PET scans) using equipment presently found in PET labs.

Key Benefits:

  • Environmentally compatible process
  • enhanced chemical selectivity
  • Readily available and inexpensive materials
  • Established protocol
  • Capable of producing radiolabelled fluoride compound for PET scanning


  • Synthesis of organo-fluorine compounds
  • Synthesis of radiolabelled biomarkers

IP Status:

St Andrews University would be happy to discuss this technology transfer opportunity.

Please use the enquiry form below to contact us


Please enter your name.

Please enter the name of the company you work for.

Is your company an SME?

Please select the country you are in.

Please select what part of the UK you are in.

Please select from the following options.

Please enter your email address.

To help us process your enquiry faster please enter some details about the information you are interested in.

Words remaining:

Related Opportunities

  • Lab in a Pill

    Scientists at the University of Glasgow have pioneered a new sensor technology, Lab-in-a-Pill, that could have major impact on the cost and effectiveness of bowel cancer treatment.

    Expires: Created:
  • Thermoelectric Sensor

    The Thermoelectric Sensor technology is a Nano-Calorimetric Sensor which measures very small changes in temperature. The IP provides a route to making the most sensitive calorimetric measurements (with a resolution of 0.1 mK).

    Expires: Created:
  • Parkinson's Disease Model

    The University of Glasgow is offering an exciting new model for the evaluation of new treatments for Parkinsons disease

    Expires: Created:
  • Combination Treatment for MRSA Nasal Carriage and MRSA-infected Wounds

    The new treatment is a combination of a peptide (ranalexin) with bacteria cell wall-digesting protein (lysostaphin), which specifically targets and kills Staphylococcus aureus, including MRSA.

    Expires: Created:
  • Synergistic antifungal combination

    Candida species are a major cause of catheter-related nosocomial bloodstream infections. We have identified that the combination of an echinocandin antifungal with certain antimicrobial peptides results in potent, synergistic inhibition of yeast pathogens in vitro, so offering a potential combinatio...

    Expires: Created:

Alerts Signup

Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities

Register Now for University Technology.com Alerts

Search Filter

Share this page

Use the buttons below to share these technology opportunities on your favourite social networking site. You can also share them from inside the individual opportunity.